ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,558,337, issued on Feb. 24, was assigned to ONCOPEPTIDES INNOVATION AB (Stockholm).
"Formulations comprising melflufen" was invented by Fredrik Lehmann (Stockholm) and Peter Teodorovic (Stockholm).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides a pharmaceutical formulation comprising (or consisting essentially of) the following components: i) melflufen, or a salt thereof; ii) propylene glycol; iii) optionally one or more physiologically acceptable aqueous solvent(s); and iv) optionally one or more additional therapeutic agent(s); or a pharmaceutical formulation comprising (or consisting essentially of) the following components: i) m...